Novartis Vaccines and Diagnostics Inc vs Wyeth et al, No. 2:08-cv-00067 (E.D. Tex. Aug. 30, 2010)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Pending before the Court is Wyeth and Wyeth Pharmaceuticals Inc.‟s (collectively “Wyeth”) Motion for Reconsideration and Objections to Magistrate Judge Everingham‟s Denial of Defendants‟ Motion to Transfer Venue to the Northern District of California. (Dkt. No. 144) The Court conducted a hearing on August 20, 2010. After considering the parties‟ arguments and the applicable law, the Court is of the opinion that Wyeth‟s motion should be DENIED. I.